Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan's First CRO CMIC On How ICH Affects Clinical Trials in Japan: An Interview with PharmAsia News (Part 1 of 2)

This article was originally published in PharmAsia News

Executive Summary

Established in 1992 as the first contract clinical trial research organization in Japan, CMIC is now one of the largest Japanese CROs and currently employs more than 2,500 employees. The company has several business segments including clinical trials, and contract manufacturing and sales, and operates in Japan, the United States, South Korea, Taiwan, Singapore, and China. CMIC's CRO business accounted for 58 percent of its sales. CMIC Corporate Officer Asia Development Moriaki Akasaki sat down with PharmAsia News Japan bureauto give his perspectives on clinical trials in Japan and other Asian countries under the influence of the International Conference on Harmonization.

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts